SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that it will
Biotech ripe for 'cascade of dealmaking' - Here are the top companies to watch By Investing.com investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.
Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) have earned an average recommendation of “Buy” from the six ratings firms that are covering the company, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock in […]